These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8791028)

  • 1. Emerging preclinical and clinical profile of 311C90: a poster review and discussion.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():19-23. PubMed ID: 8791028
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of zolmitriptan (Zomig, 311C90).
    Lipton RB; Stewart WF
    Cephalalgia; 1997 Oct; 17 Suppl 18():53-9. PubMed ID: 9399017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 311C90: increasing the options for therapy with effective acute antimigraine 5HT1B/1D receptor agonists.
    Ferrari MD
    Neurology; 1997 Mar; 48(3 Suppl 3):S21-4. PubMed ID: 9071266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolmitriptan. Introduction.
    Mathew N
    Cephalalgia; 1997 Oct; 17 Suppl 18():1-3. PubMed ID: 9399011
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine.
    Geraud GE
    Eur Neurol; 1996; 36 Suppl 2():24-7. PubMed ID: 8791029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 311C90: long-term efficacy and tolerability profile for the acute treatment of migraine. International 311C90 Long-Term Study Group.
    Zagami AS
    Neurology; 1997 Mar; 48(3 Suppl 3):S25-8. PubMed ID: 9071267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extending therapeutic options? Prospects for the future.
    Edmeads JG
    Eur Neurol; 1996; 36 Suppl 2():32-3. PubMed ID: 8791031
    [No Abstract]   [Full Text] [Related]  

  • 8. 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.
    Visser WH; Klein KB; Cox RC; Jones D; Ferrari MD
    Neurology; 1996 Feb; 46(2):522-6. PubMed ID: 8614525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness of 311C90 in the acute treatment of migraine.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():4-7. PubMed ID: 8791025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache after frequent use of serotonin agonists zolmitriptan and naratriptan.
    Limmroth V; Kazarawa Z; Fritsche G; Diener HC
    Lancet; 1999 Jan; 353(9150):378. PubMed ID: 9950449
    [No Abstract]   [Full Text] [Related]  

  • 11. Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura?
    Dowson A
    Eur Neurol; 1996; 36 Suppl 2():28-31. PubMed ID: 8791030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical safety of 311C90: aggregated data from patients and volunteers to date.
    Earl NL
    Eur Neurol; 1996; 36 Suppl 2():8-12. PubMed ID: 8791026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A triptan too far?
    Goadsby PJ
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):143-7. PubMed ID: 9489518
    [No Abstract]   [Full Text] [Related]  

  • 14. Increasing the options for effective migraine management.
    Goadsby PJ; Olesen J
    Neurology; 1997 Mar; 48(3 Suppl 3):S1-3. PubMed ID: 9071262
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
    Rolan P
    Cephalalgia; 1997 Oct; 17 Suppl 18():21-7. PubMed ID: 9399014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zolmitriptan receives migraine indication.
    Am J Health Syst Pharm; 1998 Jan; 55(2):110, 113. PubMed ID: 9465973
    [No Abstract]   [Full Text] [Related]  

  • 17. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine.
    Martin GR
    Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attacking migraine headache from beginning to end.
    Moskowitz MA; Cutrer FM
    Neurology; 1997 Nov; 49(5):1193-5. PubMed ID: 9371890
    [No Abstract]   [Full Text] [Related]  

  • 19. [Zolmitriptan].
    Le Jeunne C
    Presse Med; 1999 Sep; 28(28):1525-6. PubMed ID: 10526561
    [No Abstract]   [Full Text] [Related]  

  • 20. [Zolmitriptan].
    Monseu G; Sternon J
    Rev Med Brux; 1998 Dec; 19(6):495-9. PubMed ID: 9916496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.